In line with previous reports from our group concerning meningioma [47], also glioma cell models harboring mutant TERT promoters were hypersensitive towards YK-4-279 treatment [47] and YK-4-279 distinctly reduced TERT mRNA expression. This evidence concerns the gene TERT and meningioma.